ClickCease

Tag: research

GIOSTAR Reviews Potential Benefits of Stem Cell Therapy on Coronavirus covid-19

GIOSTAR Reviews Potential Benefits of Stem Cell Therapy on Coronavirus

Since its outbreak, coronavirus (COVID-19) has cast an unprecedented impact that has reverberated throughout the world. Scientists, government officials, and doctors have searched frantically for a remedy, to help contain further disruption. In this video, GIOSTAR Co-Founder and Chairman Dr. Anand Srivastava reports on a study examining [...]
GIOSTAR Launches Stem Cell / Cancer Research and Therapy Center in Chandigarh, India GIOSTAR Chandigarh | Office

GIOSTAR Launches Stem Cell / Cancer Research and Therapy Center in Chandigarh, India

GIOSTAR has played a pivotal role in regenerative medicine in India for many years. This trend continues with the launch of a new stem cell / cancer research and therapy center in Chandigarh, one of the country’s most prestigious cities.

GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial AdobeStock

GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial

For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.